EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prospective study of 99m Tc ‐ 3PRGD 2 SPECT / CT diagnosing metastatic lymph nodes in esophageal squamous cell carcinoma

Xiaojin Wang iD, Guichao Liu, Zhanyu Li, Jiyun Shi, Mingzhu Liang, Guining Fu, Liangzhan Lv, Shaolong Ju, Yin Wang, Wenhua Xu, Fan Wang, Qingdong Cao iD und 1 weitere

Thoracic Cancer · 2024

DOI: 10.1111/1759-7714.15421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Xiaojin Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Lymphatic Metastasis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the National Key R&D Program of China, the Zhuhai Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymph node (LN) metastasis is a significant prognostic factor for esophageal squamous cell carcinoma (ESCC), and there are no satisfactory methods for accurately predicting metastatic LNs. The present study aimed to assess the efficacy of 99m Tc‐3PRGD 2 single‐photon emission computed tomography (SPECT)/computed tomography (CT) for diagnosing metastatic LNs in ESCC.

Methods

A total of 15 enrolled patients with ESCC underwent 99m Tc‐3PRGD 2 SPECT/CT and 18F ‐ fluorodeoxyglucose positron emission tomography‐computed tomography ( 18 F‐FDG PET/CT) examinations preoperatively. High‐definition bone carving reconstruction technology (HD‐xSPECT Bone) was applied to quantitatively assess the LN's SUV max via SPECT/CT. The two methods were compared for diagnosing metastatic LNs with pathology as the gold standard.

Results

Among 15 patients, 23 metastatic lymph node stations (mLNSs) were predicted by SPECT/CT, with a mean SUV max of 2.71 ± 1.34, of which 15 were pathologically confirmed; 32 mLNSs were predicted by PET/CT with a mean SUV max of 4.41 ± 4.02, of which 17 were pathologically confirmed. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of SPECT/CT for diagnosing metastatic LNs were 62.50%, 91.30%, 85.34%, 65.22%, and 90.32%, respectively, and those of PET/CT were 70.83%, 83.70%, 81.03%, 53.13%, and 91.67%, respectively. There was no significant difference in sensitivity ( p = 0.061) or specificity ( p = 0.058) between the two methods. The AUC SPECT/CT was 0.816 and the SUV max threshold was 2.5.

Conclusion

99m Tc‐3PRGD 2 SPECT/CT might be an effective method for diagnosing metastatic LNs in ESCC, especially in combination with HD‐xSPECT Bone. The diagnostic efficiency of this method was noninferior to that of 18 F‐FDG PET/CT. The SUV max threshold of 2.5 showed the highest agreement with the pathology findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaLymphatic MetastasisHumansMaleFemaleMiddle AgedAgedProspective StudiesEsophageal NeoplasmsSingle Photon Emission Computed Tomography Computed TomographyPositron Emission Tomography Computed TomographyOrganotechnetium CompoundsLymph NodesAdultRadiopharmaceuticals

Stichwörter der Autor:innen

99mTc‐3PRGD2SPECT/CTdiagnosisesophageal squamous cell carcinomalymph node metastasis

Substanzen

Organotechnetium CompoundsRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Department of Nuclear Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
  • Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

ORCID-Profile: Xiaojin Wang, Qingdong Cao

Förderung

  • the National Natural Science Foundation of China
  • the National Key R&D Program of China
  • the Zhuhai Science and Technology Planning Project
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, X., Liu, G., Li, Z., Shi, J., Liang, M., Fu, G., Lv, L., Ju, S., Wang, Y., Xu, W., Wang, F., Cao, Q., & Shan, H. (2024). Prospective study of 99m Tc ‐ 3PRGD 2 SPECT / CT diagnosing metastatic lymph nodes in esophageal squamous cell carcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15421

Vancouver

Wang X, Liu G, Li Z, Shi J, Liang M, Fu G, et al. Prospective study of 99m Tc ‐ 3PRGD 2 SPECT / CT diagnosing metastatic lymph nodes in esophageal squamous cell carcinoma. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15421

BibTeX
@article{Wang2024,
  author = {Wang, Xiaojin and Liu, Guichao and Li, Zhanyu and Shi, Jiyun and Liang, Mingzhu and Fu, Guining and Lv, Liangzhan and Ju, Shaolong and Wang, Yin and Xu, Wenhua and Wang, Fan and Cao, Qingdong and Shan, Hong},
  title = {Prospective study of 99m Tc ‐ 3PRGD 2 SPECT / CT diagnosing metastatic lymph nodes in esophageal squamous cell carcinoma},
  journal = {Thoracic Cancer},
  year = {2024},
  doi = {10.1111/1759-7714.15421}
}
Kostenlos starten →